Silicosis prevalence and incidence among Medicare beneficiaries
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Silicosis prevalence and incidence among Medicare beneficiaries
  • Published Date:

    January 18 2019

  • Source:
    Am J Ind Med. 62(3):183-191
  • Language:
    English
Filetype[PDF-365.00 KB]


Details:
  • Alternative Title:
    Am J Ind Med
  • Description:
    Introduction: Existing epidemiologic information on silicosis relies on mortality data. Methods: We analyzed health insurance claims and enrollment information from 49 923 987 fee-for-service (FFS) Medicare beneficiaries aged ≥65 from 1999 to 2014. Three different definitions were developed to identify silicosis cases and results are presented as ranges of values for the three definitions. Results: Among FFS beneficiaries, 10 026–19 696 fit the silicosis case definitions (16-year prevalence: 20.1–39.5 per 100 000) with the highest prevalence among North American Natives (87.2–213.6 per 100 000) and those in New Mexico (83.9–203.4 per 100 000). The annual average prevalence had a significant (P <0.05) 2–5% annual decline from 2005 to 2014. The average annual number of incident cases had a significant 3–16% annual decline from 2007 to 2014. Conclusions: Silicosis is a prevalent disease among Medicare beneficiaries aged ≥65, with variation across the country. Morbidity data from health insurance claims can provide a more complete picture of silicosis burden.
  • Pubmed ID:
    30658007
  • Pubmed Central ID:
    PMC6492239
  • Document Type:
  • Collection(s):
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: